150 related articles for article (PubMed ID: 14691450)
1. MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.
Tagawa H; Karnan S; Kasugai Y; Tuzuki S; Suzuki R; Hosokawa Y; Seto M
Oncogene; 2004 Apr; 23(14):2576-81. PubMed ID: 14691450
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization.
Sakabe T; Shinomiya T; Mori T; Ariyama Y; Fukuda Y; Fujiwara T; Nakamura Y; Inazawa J
Cancer Res; 1999 Feb; 59(3):511-5. PubMed ID: 9973190
[TBL] [Abstract][Full Text] [Related]
3. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray.
Sarraf S; Tejada R; Abawi M; Oberst M; Dennis T; Simon KC; Blancato J
Cancer Genet Cytogenet; 2005 Aug; 161(1):63-9. PubMed ID: 16080959
[TBL] [Abstract][Full Text] [Related]
4. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning.
Chan AM; Takai S; Yamada K; Miki T
Oncogene; 1996 Mar; 12(6):1259-66. PubMed ID: 8649828
[TBL] [Abstract][Full Text] [Related]
6. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.
Werner CA; Döhner H; Joos S; Trümper LH; Baudis M; Barth TF; Ott G; Möller P; Lichter P; Bentz M
Am J Pathol; 1997 Aug; 151(2):335-42. PubMed ID: 9250147
[TBL] [Abstract][Full Text] [Related]
7. A novel candidate oncogene, MCT-1, is involved in cell cycle progression.
Prosniak M; Dierov J; Okami K; Tilton B; Jameson B; Sawaya BE; Gartenhaus RB
Cancer Res; 1998 Oct; 58(19):4233-7. PubMed ID: 9766643
[TBL] [Abstract][Full Text] [Related]
8. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
[TBL] [Abstract][Full Text] [Related]
9. Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene.
Kovnat A; Buick RN; Choo B; De Harven E; Kopelyan I; Trent JM; Tannock IF
Cancer Res; 1988 Sep; 48(17):4993-5000. PubMed ID: 3409229
[TBL] [Abstract][Full Text] [Related]
10. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
[TBL] [Abstract][Full Text] [Related]
11. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.
Fatima S; Chui CH; Tang WK; Hui KS; Au HW; Li WY; Wong MM; Cheung F; Tsao SW; Lam KY; Beh PS; Wong J; Law S; Srivastava G; Ho KP; Chan AS; Tang JC
Int J Mol Med; 2006 Jan; 17(1):159-70. PubMed ID: 16328025
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and characterization of a human acute monocytic leukemic cell line, SHI-1, carrying t(6;11)(q27;23) and p53 gene alteration].
Chen SN; Xue YQ; Zhang XG; Wu YF; Pan JL; Wang Y; Cen JN
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):94-9. PubMed ID: 15921626
[TBL] [Abstract][Full Text] [Related]
13. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
[TBL] [Abstract][Full Text] [Related]
14. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
[TBL] [Abstract][Full Text] [Related]
15. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
[TBL] [Abstract][Full Text] [Related]
17. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
[TBL] [Abstract][Full Text] [Related]
18. Amplification of cellular oncogenes in cancer cells.
Alitalo K
Med Biol; 1984; 62(6):304-17. PubMed ID: 6398390
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype".
Kusumoto S; Kobayashi Y; Sekiguchi N; Tanimoto K; Onishi Y; Yokota Y; Watanabe T; Maeshima AM; Ishida T; Inagaki H; Matsuno Y; Ueda R; Tobinai K
Am J Surg Pathol; 2005 Aug; 29(8):1067-73. PubMed ID: 16006802
[TBL] [Abstract][Full Text] [Related]
20. Oncogenes: preliminary studies in head and neck cancer.
Friedman WH; Rosenblum B; Loewenstein P; Thornton H; Katsantonis G; Green M
Laryngoscope; 1983 Nov; 93(11 Pt 1):1441-4. PubMed ID: 6633116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
